The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease

Blood

Volumn 92, Issue 9, 1998, Pages 3362-3367

  Bose, Shikha ^a   Deininger, Michael ^a   Gora Tybor, Joanna ^a   Goldman, John M ^a   Melo, Junia V ^a,b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; CANCER REGRESSION; CHRONIC MYELOID LEUKEMIA; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0032211172     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.9.3362     Document Type: Article

References (29)

1. Melo JV: The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 88:2375, 1996
2. Daley GQ, Van Etten RA, Baltimore D: Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247:824, 1990
3. Kelliher M, Knott A, McLaughlin J, Witte ON, Rosenberg N: Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene. Mol Cell Biol 11:4710, 1991
4. Voncken JW, Kaartinen V, Pattengale PK, Germeraad WT, Groffen J, Heisterkamp N: BCR/ABL P210 and P190 cause distinct leukemia in transgenic mice. Blood 86:4603, 1995
5. Cross NCP: Assessing residual disease, in Goldman JM (ed): Chronic Myeloid Leukaemia. London, UK, Bailliere Tindall, 1997, p 357
6. Fialkow PJ, Martin PJ, Najfeld V, Penfold GK, Jacobson RJ, Hansen JA: Evidence for a multistep pathogenesis of chronic myelogenous leukemia. Blood 58:158, 1981
7. Hagemeijer A, Smit EM. Lowenberg B, Abels J: Chronic myeloid leukemia with permanent disappearance of the Ph1 chromosome and development of new clonal subpopulations. Blood 53:1, 1979
8. Ariyama T, Inazawa J, Uemura Y, Kakazu N, Maekawa T, Urase F, Irimajiri K, Horiuchi A, Nakamura Y, Abe T: Clonal origin of Philadelphia chromosome negative cells with trisomy 8 appearing during the course of alpha-interfere n therapy for Ph positive chronic myelocytic leukemia. Cancer Genet Cytogenet 81:20, 1995
9. Bose S, Chowdhry VP, Saxena R, Kucheria K: Lymphoid blast crisis during complete cytogenetic remission following interferon-α and hydroxyurea therapy. Acta Haemaiol 98:155, 1997
10. Biernaux C, Loos M, Sels A, Huez G, Stryckmans P: Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 86:3118, 1995
11. Deininger MWN. Bose S, Gora-Tybor J, Goldman JM, Melo JV: Selective induction of leukemia-associated fusion genes by high-dose ionizing radiation. Cancer Res 58:421, 1998
12. Loos JA, Roos D: Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. 3. Stimulation by tuberculin and allogenic cells. Exp Cell Res 79:136, 1973
13. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
14. Deininger MWN. Goldman JM, Lydon NB, Melo JV: The tyrosine kinase inhibitor CGP57148B selectively inhibits the growth of BCR-ABL positive cells. Blood 90:3691, 1997
15. Cross NC, Melo JV, Feng L, Goldman JM: An optimized multiplex polymerase chain reaction (PCR) for detection of BCR-ABL fusion mRNAs in haematological disorders. Leukemia 8:186, 1994
16. Melo JV, Gordon DE, Cross NC, Goldman JM: The ABL-BCR fusion gene is expressed in chronic myeloid leukemia. Blood 81:158, 1993
17. Cross NCP: Detection of BCR-ABL by RT-PCR in haematological malignancies, in Cotter FE (ed): Molecular Diagnosis of Cancer. Totowa, NJ, Humana, 1996, p 25
18. Selleri L, Emilia G, Luppi M, Temperani P, Zucchini P, Tagliafico E, Artusi T, Sarti M, Donelli A, Castoldi GL, Ferrari S, Torelli U, Torelli G: Chronic myelogenous leukemia with typical clinical and morphological features can be Philadelphia chromosome negative and "bcr negative." Hematol Pathol 4:67, 1990
19. Liu Y, Hernandez AM, Shibata D, Cortopassi GA: BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci USA91:8910, 1994
20. Limpens J, Stad R, Vos C, de Vlaam C, de Jong D, van Ommen GJ, Schuuring E, Kluin PM: Lymphoma-associated translocation t(14; 18) in blood B cells of normal individuals. Blood 85:2528, 1995
21. Vickers M: Estimation of the number of mutations necessary to cause chronic myeloid leukaemia from epidemiological data. Br J Haematol 94:l, 1996
22. Okamoto K, Karasawa M, Sakai H, Ogura H, Morita K, Naruse T: A novel acute lymphoid leukaemia type BCR/ABL transcript in chronic myelogenous leukaemia. Br J Haematol 96:611, 1997
23. Melo JV: BCR-ABL gene variants. Clin Haematol 10:203, 1997
24. Miyamura K, Tahara T, Tanimoto M, Morishita Y, Kawashima K, Morishima Y, Saito H, Tsuzuki S, Takeyama K, Kodera Y, Matsuyama K, Hirabayashi N, Yamada H, Naito K, Imai K, Sakamaki H, Asai O, Mizutani S: Long persistent bcr-abl positive transcript detected by polymerase chain reaction after marrow transplant for chronic myelogenous leukemia without clinical relapse: A study of 64 patients. Blood 81:1089, 1993
25. Lin F, van Rhee F, Goldman JM, Cross NC: Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation. Blood 87:4473, 1996
26. Mackinnon S, Barnett L, Heller G: Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplant 17:643, 1996
27. van Rhee F, Lin F, Cross NC, Reid CD, Lakhani AK, Szydlo RM, Goldman JM: Detection of residual leukaemia more than 10 years after allogeneic bone marrow transplantation for chronic myelogenous leukaemia. Bone Marrow Transplant 14:609, 1994
28. Lin F, Kirkland MA, van Rhee FV, Chase A, Coulthard S, Bungey J, Goldman JM, Cross NC: Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia. Bone Marrow Transplant 18:1147, 1996
29. Chissoe SL, Bodenteich A, Wang YF, Wang YP, Burian D, Clifton SW, Crabtree J, Freeman A, Iyer K, Jian L, Ma Y, McLaury HJ, Pan HQ, Sarhan OH, Toth S, Wang Z, Zhang G, Heisterkamp N, Groffen J, Roe B A: Sequence and analysis of the human ABL gene, the BCR gene, and regions involved in the Philadelphia chromosomal translocation. Genomics 27:67, 1995